Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Nuvectra Corp (NVTR) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/16/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
04/20/2020 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "Monthly Operating Report for the month ended March 31, 2020 as filed with the Bankruptcy Court on April 17, 2020"
03/25/2020 8-K Quarterly results
03/16/2020 8-K Quarterly results
02/14/2020 SC 13G First Light Asset Management, LLC reports a 0% stake in Nuvectra Corporation
02/14/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2020 8-K Quarterly results
01/31/2020 8-K Quarterly results
01/15/2020 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "Monthly Operating Report for the month ended December 31, 2019 as filed with the Bankruptcy Court on January 15, 2020",
"Order as entered by the Bankruptcy Court on January 13, 2020"
12/31/2019 8-K Quarterly results
12/17/2019 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
11/22/2019 8-K Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm...
11/14/2019 8-K Quarterly results
11/13/2019 GN Nuvectra® maintient la prise en charge de ses patients actuels dotés de l'implant Algovita® alors que la société dépose volontairement une requête en vertu du chapitre 11
11/13/2019 GN Nuvectra® unterstützt weiterhin bestehende Patienten mit dem Algovita®-Implantat, während das Unternehmen freiwillig ein Verfahren gemäß Chapter 11 beantragt
11/13/2019 GN Nuvectra®???????11???????Algovita®?????????
11/13/2019 GN Nuvectra® ???? 11 ?????,????? Algovita® ???????
11/13/2019 GN Nuvectra® Terus Mendukung Para Pasien dengan Implan Algovita® Saat Perusahaan Tersebut dengan Sukarela Mengajukan Perlindungan Bab 11
11/13/2019 GN ??????11???????????????????Algovita® Implant?????????????
11/13/2019 GN Nuvectra®, ????? 11? ??? ???? ??? ??? ??, ?? Algovita® ?? ?? ?? ???? ????? ??? ??
11/13/2019 GN Nuvectra® Terus Menyokong Pesakit Semasa dengan Implan Algovita® sementara Syarikat Memfailkan Bab 11 secara Sukarela
11/13/2019 GN Nuvectra® continua a apoiar seus pacientes com o Implante Algovita® enquanto a empresa entra com pedido de recuperação judicial
11/13/2019 GN Nuvectra® continúa apoyando a los pacientes existentes con el implante Algovita®, mientras la Compañía presenta petición de reestructuración voluntaria bajo el Capítulo XI
11/13/2019 GN Nuvectra® ????????????????????????????????????????????????????????? Algovita® ??????????????????????????????????????????????????? 11
11/13/2019 8-K Quarterly results
11/12/2019 GN Nuvectra® Continuing to Support Current Patients with the Algovita® Implant as Company Voluntarily Files for Chapter 11
10/18/2019 8-K Other Events, Financial Statements and Exhibits
Docs: "Investor Contact:"
09/20/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Employment Agreement between Nuvectra Corporation and Ms. Jennifer Kosharek",
"Nuvectra ® Appoints Jennifer Kosharek as Chief Financial Officer"
09/20/2019 GN Nuvectra® Appoints Jennifer Kosharek as Chief Financial Officer
08/29/2019 8-K Cost Associated with Exit or Disposal Activities, Other Events, Financial Statements and Exhibits
Docs: "Nuvectra ® Exploring Strategic Options to Enhance Shareholder Value"
08/26/2019 GN Nuvectra® Exploring Strategic Options to Enhance Shareholder Value
07/31/2019 10-Q Quarterly Report for the period ended June 30, 2019
07/31/2019 8-K Quarterly results
Docs: "Nuvectra ® Reports Second Quarter 2019 Financial Results"
07/26/2019 EFFECT Form EFFECT - Notice of Effectiveness:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy